Healthcare Stock showing Positive Movement: DaVita HealthCare Partners Inc (NYSE:DVA)

0
81
Money city

DaVita HealthCare Partners Inc (NYSE:DVA):
The Company gained 0.64% and finished at $77.34. The daily volume was measured at 879,678.00 shares. The 52-week high of the share price is $84.40 and the 52-week low is $61.36. The company has a market cap of $15.99 billion. The stock has a P/E ratio of 34.85. Its latest closing price has a distance of 2.75% from SMA20 and is 4.86% up than SMA50. The stock currently has Price to Sales (P/S) value of 1.14 where Price to Book (P/B) value stands at 3.36. The company is currently showing ROA (Return on Assets) value of 2.60% where ROE (Return on Equity) is 9.70%. Return on equity (ROE) measures the rate of return on the ownership interest (shareholders’ equity) of the common stock owners. It measures a firm’s efficiency at generating profits from every unit of shareholders’ equity (also known as net assets or assets minus liabilities).

By looking at DaVita HealthCare Partners Inc (NYSE:DVA) YTD (year to date) performance, the stock shows Positive value of 10.95%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.

The High price target of the company’s Share is at $90.00 based on the calculations and analysis of 9 brokers. According to the analysts, the company has the Low Price target of $71.00 whereas, the Mean Target is estimated by the brokers is $78.56.

Most Recent Upgrades & Downgrades for DaVita HealthCare Partners Inc (NYSE:DVA) was initiated On Sep 16, 2015 where JP Morgan Initiated” the stock to “Neutral”.

While Looking at the Analyst Estimates of the company, The Average Earnings Estimate for the Current Fiscal quarter is measured as $1.00 by 11.00 analysts. They are also projecting the Low EPS estimate as $0.94 as compared to the Higher EPS estimate of $1.11.

Now when we talk about Revenue Estimate for the current Fiscal Quarter, Average Revenue Estimate of DaVita HealthCare Partners Inc (NYSE:DVA) is projected as $3.67 Billion where Low Revenue estimate and High Revenue Estimate are $3.53 billion and $3.82 Billion respectively by 10 Analysts.

The EPS (Earnings per share) Trend for the current Quarter is estimated at $1.00 per share while the Trend for 7 days ago was $0.98. The EPS Trend for 30, 60 and 90 Days ago were $0.98, $0.99 and $0.99.

DaVita HealthCare Partners Inc (NYSE:DVA) Profile:

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, Kidney Care and HealthCare Partners. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2015, it provided dialysis and administrative services in the United States through a network of 2,251 outpatient dialysis centers serving approximately 180,000 patients; operated 118 outpatient dialysis centers located in 10 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.